These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9614724)

  • 41. [Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis].
    de Haan RJ; Polman CH
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2168-71. PubMed ID: 8984352
    [No Abstract]   [Full Text] [Related]  

  • 42. Interferon beta treatment for multiple sclerosis.
    Goodin DS
    Lancet; 1999 Feb; 353(9151):495-6; author reply 497-8. PubMed ID: 9989741
    [No Abstract]   [Full Text] [Related]  

  • 43. Disease modifying treatment in multiple sclerosis.
    Fuller GN; Bone I
    J Neurol Neurosurg Psychiatry; 2001 Dec; 71 Suppl 2(Suppl 2):ii20-1. PubMed ID: 11701780
    [No Abstract]   [Full Text] [Related]  

  • 44. Interferon beta treatment for multiple sclerosis.
    Galazka A
    Lancet; 1999 Feb; 353(9151):495; author reply 497-8. PubMed ID: 9989740
    [No Abstract]   [Full Text] [Related]  

  • 45. Interferon beta treatment for multiple sclerosis.
    Herndon RM
    Lancet; 1999 Feb; 353(9151):494-5; author reply 497-8. PubMed ID: 9989739
    [No Abstract]   [Full Text] [Related]  

  • 46. Interferon β for secondary progressive multiple sclerosis: a systematic review.
    La Mantia L; Vacchi L; Rovaris M; Di Pietrantonj C; Ebers G; Fredrikson S; Filippini G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):420-6. PubMed ID: 22952326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant hCG (OVIDREL) and recombinant interferon-beta1a (REBIF) (No. 13 in a series of articles to promote a better understanding of the use of genetic engineering).
    Piani D; Malkowski JP
    J Biotechnol; 2001 May; 87(3):281-3. PubMed ID: 11474553
    [No Abstract]   [Full Text] [Related]  

  • 48. The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TWiST analysis.
    Schwartz CE; Coulthard-Morris L; Cole B; Vollmer T
    Arch Neurol; 1997 Dec; 54(12):1475-80. PubMed ID: 9400356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anaphylactoid reaction to methyl prednisolone developing after starting treatment with interferon beta-1b.
    Clear D
    J Neurol Neurosurg Psychiatry; 1999 May; 66(5):690. PubMed ID: 10348645
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical effects and tolerability of high-dose, high-frequency recombinant interferon beta-1a in patients with multiple sclerosis: maximizing therapy through long-term adherence.
    Boyko AN
    Expert Opin Biol Ther; 2010 Apr; 10(4):653-66. PubMed ID: 20218924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interferon beta treatment for multiple sclerosis.
    O'Connor P
    Lancet; 1999 Feb; 353(9151):496; author reply 497-8. PubMed ID: 9989742
    [No Abstract]   [Full Text] [Related]  

  • 52. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.
    Nikfar S; Rahimi R; Abdollahi M
    Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interferon beta in the management of multiple sclerosis.
    Pender MP
    Aust N Z J Med; 1996 Jun; 26(3):343. PubMed ID: 8811205
    [No Abstract]   [Full Text] [Related]  

  • 54. New tools for biotech product development.
    Quay S
    Biotechnology (N Y); 1995 Apr; 13(4):319-20. PubMed ID: 9678946
    [No Abstract]   [Full Text] [Related]  

  • 55. Role of interferons in demyelinating diseases.
    Arnason BG; Toscas A; Dayal A; Qu Z; Noronha A
    J Neural Transm Suppl; 1997; 49():117-23. PubMed ID: 9266421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Needed in MS: evidence, not EVIDENCE.
    Kieburtz K; McDermott M
    Neurology; 2002 Nov; 59(10):1482-3. PubMed ID: 12451186
    [No Abstract]   [Full Text] [Related]  

  • 57. [Interferon-beta 1a in therapy of relapsing-remitting multiple sclerosis].
    Hartung HP; Hohlfeld R
    Nervenarzt; 1997 Jun; 68(6):525-7. PubMed ID: 9312688
    [No Abstract]   [Full Text] [Related]  

  • 58. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract]   [Full Text] [Related]  

  • 59. Interferon beta treatment in multiple sclerosis: the European clinical trials.
    Comi G; Martinelli V; Filippi M
    Mult Scler; 1996 Jul; 1(6):317-20. PubMed ID: 9345407
    [No Abstract]   [Full Text] [Related]  

  • 60. Interferon beta-1A for relapsing multiple sclerosis.
    Med Lett Drugs Ther; 1996 Jul; 38(979):63-4. PubMed ID: 8692073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.